共 50 条
- [31] A KEY TIF1Γ EPITOPE MAY FACILITATE THE IDENTIFICATION OF PATIENTS AT HIGHEST RISK OF CANCER ASSOCIATED MYOSITISANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 369 - 370Riddell, V.Mcmorrow, F.Oldroyd, A.Deakin, C.Lamb, J.Chinoy, H.Wedderburn, L.Bagby, S.Mchugh, N.Tansley, S.
- [32] Predictors of Positive Retroperitoneal Lymph Nodes in Patients With High Risk Testicular CancerJOURNAL OF UROLOGY, 2011, 186 (06): : 2245 - 2248Williams, S. B.Kacker, R.Winston, D.Bahnson, E.Steele, G. S.Richie, J. P.
- [33] A novel risk classifier to predict the in-hospital death risk of nosocomial infections in elderly cancer patientsFRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13Jiang, AiminLi, YimengZhao, NiShang, XiaoLiu, NaWang, JingjingGao, HuanFu, XiaoRuan, ZhipingLiang, XuanTian, TaoYao, Yu
- [34] Anti-TIF-1 Antibody Positivity Is Associated with a Five-Fold Increase in Cancer Risk in the Idiopathic Inflammatory MyopathiesARTHRITIS & RHEUMATOLOGY, 2017, 69Oldroyd, AlexanderSergeant, Jamie C.New, PaulMcHugh, Neil J.Betteridge, ZoeLamb, JanineOllier, WilliamCooper, RobertChinoy, Hector
- [35] ANTI-TIF-1 ANTIBODY POSITIVITY IS ASSOCIATED WITH A FIVE-FOLD INCREASE IN CANCER RISK IN THE IDIOPATHIC INFLAMMATORY MYOPATHIESRHEUMATOLOGY, 2018, 57Oldroyd, AlexanderSergeant, JamieNew, PaulMcHugh, NeilBetteridge, ZoeLamb, JanineOllier, WilliamCooper, RobertChinoy, Hector
- [36] TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositisRHEUMATOLOGY, 2021, 60 (12) : 5863 - 5867Cordel, NadegeDerambure, CelineCoutant, SophieMariette, XavierJullien, DenisDebarbieux, SebastienChosidow, OlivierMeyer, AlainBessis, DidierJoly, PascalMathian, AlexisLevesque, HerveSabourin, Jean-ChristopheTournier, IsabelleBoyer, Olivier
- [37] The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease ProgressionPATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 295 - 305Varga, NorbertMozes, JohannaKeegan, HelenWhite, ChristineKelly, LynnePilkington, LorettoBenczik, MartaZsuzsanna, SchaffSobel, GaborKoiss, RobertBabarczi, EditNyiri, MiklosKovacs, LauraAttila, SebeKaltenecker, BorbalaGeresi, AdriennKocsis, AdriennO'Leary, JohnMartin, Cara M.Jeney, Csaba
- [38] IDENTIFICATION OF NOVEL BIOMARKERS FOR LUNG CANCER RISK IN HIGH LEVELS OF RADON BY PROTEOMICS: A PILOT STUDYRADIATION PROTECTION DOSIMETRY, 2019, 184 (3-4) : 496 - 499Autsavapromporn, N.Dukaew, N.Wongnoppavich, A.Chewaskulyong, B.Roytrakul, S.Klunklin, P.Phantawong, K.Chitapanarux, I.Sripun, P.Kritsananuwat, R.Amphol, S.Pornnumpa, C.Suzuki, T.Kudo, H.Hosoda, M.Tokonami, S.
- [39] XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer PatientsFRONTIERS IN ONCOLOGY, 2020, 9Salama, Esraa A.Adbeltawab, Reda E.El Tayebi, Hend M.
- [40] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patientsJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Lu, HailingPollack, SethSomaiah, NeetaChawla, SantHwu, PatrickVignali, MarissaRytlewski, JulieGnjatic, Sachater Meulen, Jan